CYP2D6 and Anxiety: Considering data on the increased likelihood of adverse events in patients with a slow metabolism of duloxetine (the GA and GG genotypes within the CYP2D6), who have relatively higher drug concentrations in their blood at similar doses [17], it is likely that the potentially more frequent occurrence of adverse events in this group could lead to a greater severity of anxiety reactions.